Methods: We systematically searched PubMed, EMBASE, Cochrane CENTRAL, and Google
Scholar for eligible randomized controlled trials (RCTs) comparing IV iron replacement …

Objective: We conducted a meta-analysis of randomized clinical trials evaluating the clinical
effects of ferric carboxymaltose therapy compared to other intravenous iron in improving …

Background. Real‐world evidence of the efficacy and safety of ferric carboxymaltose (FCM)
infusion in Indian pregnant women with iron deficiency anemia (IDA) is lacking. Objective …

Background Parenteral iron preparations, like ferric carboxymaltose (FCM), are commonly
used to manage moderate-to-severe iron deficiency anemia (IDA). Real-world data on …

Results The pre-treatment ferritin and Hb significantly increased from 10.3±2.3 µg/l and
7.99±0.6 g/dl, respectively, to 139.5±1.9 and 14.04±0.45, respectively, 6-weeks after FCM …

Background There is limited clinical evidence of ferric carboxymaltose injection (FCM)
usage in Indian pregnant women. We assessed the efficacy and safety of FCM in Indian …

Background Iron absorption is disturbed after Roux-en-Y gastric bypass (RYGB) and iron
deficiency with or without anaemia affects almost half of all patients. Intravenous iron is an …

Iron deficiency anemia (IDA) during pregnancy arises because of preexisting inadequate
stores or complex physiological changes and can lead to serious maternal and fetal …

Hemoglobin A1c (HbA1c) is widely used as a diagnostic tool for diabetes. Many clinical
conditions affect erythrocyte turnover which influence HbA1c levels. These levels are …

Iron deficiency anemia (IDA) is a major health burden among women in Asia. Key issues in
IDA management in Asia are under‐diagnosis and under‐treatment. The lack of Asia …